PaTHway CHINA TRIAL: A Trial to Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism
Clinical trial NCT05387070 · COMPLETED
Trial details
- NCT number
- NCT05387070
- Sponsor
- Visen Pharmaceuticals (Shanghai) Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-28
- Primary completion
- 2023-01-04
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.